Taysha Gene Therapies, Inc. (TSHA) SEC filings

TSHA SEC filings moved a median of +0.29% by the close. TSHA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TSHA overview →

60 measured TSHA SEC filing events.

Where these TSHA SEC filings landedvs 58 measured TSHA SEC filing reactions
TSHA SEC filingMiddle 50% · -3.44% to +5.82%Zero: 0.00%Median: +0.29%Median +0.29%-8.00%0+8.00%
Middle 50% of TSHA SEC filing reactions-3.44% to +5.82%
Median reaction (to close)+0.29%
Measured reactions58
Point-in-time · zero look-ahead

Half of the 58 TSHA SEC filing events with a measured close landed between -3.44% and +5.82%; 53% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Taysha Gene Therapies, For: Jun 30SEC filing · Form 10-Q+1.98%+5.87%
Form 8-K Taysha Gene Therapies, For: Aug 11SEC filing · Form 8-K+1.98%+5.87%
Form 8-K Taysha Gene Therapies, For: Jun 24SEC filing · Form 8-K+1.31%+3.76%
Form 8-K Taysha Gene Therapies, For: Jun 22SEC filing · Form 8-K+1.54%+0.46%
Form 8-K Taysha Gene Therapies, For: Jun 01SEC filing · Form 8-K-1.06%-2.29%
Form 10-Q Taysha Gene Therapies, For: Mar 31SEC filing · Form 10-Q+0.08%+5.60%
Form 8-K Taysha Gene Therapies, For: May 06SEC filing · Form 8-K+0.08%+5.60%
Form ARS Taysha Gene Therapies, For: Dec 31SEC filing · Form ARS-0.94%+5.66%
Form DEF 14A Taysha Gene Therapies, For: Jun 01SEC filing · Form DEF-0.94%+5.66%
Form DEFA14A Taysha Gene Therapies,SEC filing · Form DEFA14A-0.94%+5.66%
Form 10-K Taysha Gene Therapies, For: Dec 31SEC filing · Form 10-K-3.52%+0.22%
Form 8-K Taysha Gene Therapies, For: Mar 19SEC filing · Form 8-K-3.52%+0.22%
Form S-8 Taysha Gene Therapies,SEC filing · Form S-8+2.45%+0.00%
Form 10-Q Taysha Gene Therapies, For: Sep 30SEC filing · Form 10-Q-6.29%-0.47%
Form 8-K Taysha Gene Therapies, For: Nov 04SEC filing · Form 8-K-6.29%-0.47%
Form S-3ASR Taysha Gene Therapies,SEC filing · Form S-3ASR-6.29%-0.47%
Form 8-K Taysha Gene Therapies, For: Oct 16SEC filing · Form 8-K-2.45%-3.67%
Form 8-K Taysha Gene Therapies, For: Oct 09SEC filing · Form 8-K-0.20%-2.34%
Form 8-K Taysha Gene Therapies, For: Oct 02SEC filing · Form 8-K+5.97%+21.39%
Form 10-Q Taysha Gene Therapies, For: Jun 30SEC filing · Form 10-Q+0.00%—
Form 8-K Taysha Gene Therapies, For: Aug 12SEC filing · Form 8-K-1.51%—
Form 8-K Taysha Gene Therapies, For: Jun 02SEC filing · Form 8-K-3.95%-4.47%
Form 8-K Taysha Gene Therapies, For: May 28SEC filing · Form 8-K+0.56%+0.37%
Form 8-K/A Taysha Gene Therapies, For: May 28SEC filing · Form 8-K-0.53%-3.51%
Form 8-K Taysha Gene Therapies, For: May 28SEC filing · Form 8-K-0.53%-3.51%
Form 10-Q Taysha Gene Therapies, For: Mar 31SEC filing · Form 10-Q+5.00%+2.40%
Form 8-K Taysha Gene Therapies, For: May 15SEC filing · Form 8-K+5.00%+2.40%
Form DEFR14A Taysha Gene Therapies,SEC filing · Form DEFR14A+1.83%+5.94%
Form ARS Taysha Gene Therapies, For: Dec 31SEC filing · Form ARS+4.75%+21.09%
Form DEF 14A Taysha Gene Therapies, For: Jun 02SEC filing · Form DEF+4.75%+21.09%
Form DEFA14A Taysha Gene Therapies,SEC filing · Form DEFA14A+4.75%+21.09%
Form PRE 14A Taysha Gene Therapies, For: Jun 02SEC filing · Form PRE-0.86%+7.33%
Form 10-K Taysha Gene Therapies, For: Dec 31SEC filing · Form 10-K-6.11%-10.00%
Form 8-K Taysha Gene Therapies, For: Feb 26SEC filing · Form 8-K-6.11%-10.00%
Form S-8 Taysha Gene Therapies,SEC filing · Form S-8-3.17%+2.12%
Form EFFECT Taysha Gene Therapies,SEC filing · Form EFFECT+1.09%+0.00%
Form S-3 Taysha Gene Therapies,SEC filing · Form S-3+0.48%-2.43%
Form 10-Q Taysha Gene Therapies, For: Sep 30SEC filing · Form 10-Q+14.22%+11.28%
Form 8-K Taysha Gene Therapies, For: Nov 13SEC filing · Form 8-K+14.22%+11.28%
Form 10-Q Taysha Gene Therapies, For: Jun 30SEC filing · Form 10-Q+1.40%-4.67%
Form 8-K Taysha Gene Therapies, For: Aug 12SEC filing · Form 8-K+1.40%-4.67%
Form 8-K Taysha Gene Therapies, For: Jun 25SEC filing · Form 8-K-2.56%-8.93%
Form 8-K Taysha Gene Therapies, For: Jun 26SEC filing · Form 8-K-0.91%+3.59%
Form 8-K Taysha Gene Therapies, For: Jun 18SEC filing · Form 8-K-15.87%-21.43%
Form 8-K Taysha Gene Therapies, For: May 29SEC filing · Form 8-K+2.53%+8.54%
Form 10-Q Taysha Gene Therapies, For: Mar 31SEC filing · Form 10-Q+4.40%+24.40%
Form 8-K Taysha Gene Therapies, For: May 14SEC filing · Form 8-K+4.40%+24.40%
Form ARS Taysha Gene Therapies, For: Dec 31SEC filing · Form ARS+0.63%-5.42%
Form DEF 14A Taysha Gene Therapies, For: May 29SEC filing · Form DEF+0.63%-5.42%
Form DEFA14A Taysha Gene Therapies,SEC filing · Form DEFA14A+0.63%-5.42%
Form 10-K Taysha Gene Therapies, For: Dec 31SEC filing · Form 10-K-1.70%+0.00%
Form 8-K Taysha Gene Therapies, For: Mar 19SEC filing · Form 8-K-1.70%+0.00%
Form S-8 Taysha Gene Therapies,SEC filing · Form S-8-1.70%+0.00%
Form 8-K Taysha Gene Therapies, For: Jan 10SEC filing · Form 8-K+0.26%-6.32%
Form 8-K Taysha Gene Therapies, For: Dec 14SEC filing · Form 8-K+1.38%+2.07%
Form S-8 Taysha Gene Therapies,SEC filing · Form S-8+1.38%+2.07%
Form 8-K Taysha Gene Therapies, For: Nov 15SEC filing · Form 8-K-3.01%-5.42%
Form 10-Q Taysha Gene Therapies, For: Sep 30SEC filing · Form 10-Q+16.67%+12.00%
Form 8-K Taysha Gene Therapies, For: Nov 14SEC filing · Form 8-K+16.67%+12.00%
Form 8-K Taysha Gene Therapies, For: Oct 30SEC filing · Form 8-K-2.02%-3.23%
That’s how TSHA usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More TSHA: earnings → · analyst actions → · TSHA overview →